Contracts & Grants

Information is courtesy of the Office of Sponsored Projects. Each listing includes the faculty member's name and school(s) appointments at The University of Texas Health Science Center at Houston, contracting or granting agency, funding amount and project title.

New

Noriaki Aoki, School of Health Information Sciences, Schull Institute, $12,182, Research in Health Informatics.

Roberto C. Arduino, Medical School (MS), Pfizer Inc., $9,150, A Multi-Center, Open-Label, Expanded Access Trial of Maraviroc.

Jan Bressler, School of Public Health (SPH), National Institutes of Health (NIH), $334,125, DNA Methylation Profiles in Polygenic Mouse Model of Diet-Induced Obesity.

John H. Byrne, MS and Graduate School of Biomedical Sciences (GSBS), NIH, $268,895, Confocal Imaging System.

Xianglin L. Du, SPH, Agency for Healthcare Research and Quality, $979,451, Postmarketing Surveillance of Toxicities Associated with Cancer Chemotherapy.

Carmel B. Dyer, MS, Harris County Hospital District, $21,700, Gateway to Care Contract.

Miguel Escobar, MS, New England Research Institute Inc., $29,460, Rituximab for the Treatment of Inhibitors in Congenital Hemophilia A: The RICH Study.

Maria E. Fernandez, SPH, Saint Louis University, $60,971, Sustainable Strategies for Increasing CIS Use Among African Americans and Hispanics.

Susan P. Fisher-Hoch, SPH and GSBS, UT San Antonio, $5,214, Biological and Genetic Factors Associated with Obesity in Hispanic Adolescents.

Charles E. Ford, SPH, Kaiser Permanente Northern California, $18,543, The Enigma of Placebo Adherence.

Kenichi Fujise, Administration and Finance (A&F) and GSBS, UT Austin, $25,000, TI-3D Identification of Novel Fortilin Inhibitors. UTA Award Title Is Texas Institute for Drug and Diagnostic Development.

Michael J. Gambello, MS and GSBS, Department of Defense, $99,945, Targeted Disruption of the TSC2 Gene n the Mouse Cerebellum.

Nicole R. Gonzales, MS, Imarx Therapeutics, $29,120, A Phase 1-2, Randomized, Placebo-Controlled, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, and Activity of Ascending Single Doses of MRX-801 with Continuous Ultrasound Administration in Subjects with Acute Ischemic Stroke Receiving Treatment with Intravenous Tissue Plasminogen Activator.

Deanna E. Grimes, School of Nursing (SON), UT Health Science Center at Houston, $19,569, Collaboration to Provide Educational Outreach of the DSN Program on the UT Brownsville/Texas Southmost College Campus.

Carin A. Hagberg, MS, Hospira Inc., $74,950, A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation during Monitored Anesthesia Care.

David L. Haviland, A&F and GSBS, Opexa Therapeutics Inc., $20,797, Sponsored Testing Agreement with Opexa Therapeutics.

Keith Hoots, MS and GSBS, Cornell University, $2,347, Females with Severe or Moderate Hemophilia A or B: A Multi-Center Study.

Vasanthi Jayaraman, MS and GSBS, Baylor College of Medicine, $25,751, Structure-Function Investigations of Glutamate Receptors Using Spectroscopy and Electrophysiology (Houston Area Molecular Biophysics Program).

Bruce C. Kone, MS and GSBS, Heart Rhythm Society, $40,000, Modulation of RyR2 by CaMKII in Atrial Fibrillation.

Maureen D. Mayes, MS, Georgetown University Medical Center, $13,000, The Natural History and Outcome of Scleroderma Patients at High Risk or with Early Pulmonary Hypertension. PHAROS: Pulmonary Hypertension Assessment Registry of Scleroderma; and Mediquest Therapeutics Inc., $17,600, Open Label Study of a Topical Gel Formulation of Nitroglycerin, MQX- 503 in the Treatment and Prevention of Raynaud's Phenomenon.

Barbara E. Murray, MS and GSBS, Intercell AG, $97,500, Vaccination with Enterococcus Faecalis Proteins.

Hope Northrup, MS and GSBS, Tuberous Sclerosis Alliance, $4,425, TSC Clinic Development Award.

Luis Ostrosky-Zeichner, MS, Pfizer Inc., $705,000, Phase IV, Open-Label, Non-Comparative Trial of IV Anidulafungin Followed by Oral Azole Therapy for the Treatment of Candidemia and Invasive Candidiasis.

Blanca I. Restrepo, MS and GSBS, UT San Antonio, $22,742, Borderplex - Susceptibility to a Pulmonary Infection in Type 2 Diabetes.

Mya C. Schiess, MS, University of Rochester, $52,152, A Randomized, Double-Blind, Active and Placebo-Controlled, Efficacy Study of Pramipexole.

Hongbin Wang, SHIS, Department of the Air Force, $301,477, Exploring the Effectiveness of Attention Manipulations on Operator Performance in C2 Task: Empirical Investigations.

M. Neal Waxham, MS and GSBS, Baylor College of Medicine, $25,751, Application of Fluorescence Correlation Spectroscopy (FCS) to Understand the Complexities of Intracellular Diffusion.

Z. Hong Zhou, MS and GSBS, National Institutes of Health (NIH), $1,503,438, HCMV Envelope and Tegument Structures: Mechanisms of Viral Entry and Assembly.

Renewal

Jacqueline T. Hecht, MS and GSBS, NIH, $1,827,957, Mapping Nonsyndromic Cleft Lip and Palate Genetic Loci.

Transfer

David D. McPherson, MS, NIH, $598,711, Echogenic Targeted Liposomes: Transfection/Drug Delivery.

Previous story Next story